Come meet Cmed experts at ASCO 2019 to discuss how our experience of oncology research can advance your development programs. With experience of over 100 global oncology studies in more than 1,400 clinical investigative sites, as well as encapsia, our innovative clinical data platform, we can offer solutions that:
Overcome the challenges of oncology and immuno-oncology trials Cover Phase I to Phase III programs Combine extensive oncology expertise across medical, scientific, regulatory and operational teams Provide a unique immediacy of data, insights and actions and bridge the gap among efficacy and safety Improve efficiencies at site: using encapsia, they have a choice of modern, intuitive data capture options, including mobile applications and benefit from no database downtime when studies are amended Our Cmed operational and business development teams will be in the ASCO conference and exhibition (booth 6103) and available to discuss your clinical trial needs.
Challenges and Opportunities in Clinical Data Management
21 Mar 2019
A recent survey on the challenges and opportunities in clinical data management by Pharma Intelligence reveals the most pressing issues today include the absence of real-time access to clinical trial data and that 90% of the effort involved in aggregating, cleaning and transforming data is manual. Moreover, over 80% of the respondents considered that incomplete and inconsistent data represents the top issue for regulatory compliance. Lastly, perhaps one of the most important findings was that eSource data is the future - finding ways to clean and manage new forms of data will be the next step in the progress of clinical trials.
We are excited to announce that our Boston office has moved to a new location in central Cambridge, just a few blocks away from our old address.
This new office is a modern, inviting space that offers a better environment to meet clients and is in close proximity to the busy Cambridge pedestrian corridor.
This move follows our 2018 investments to move our US headquarters to a new office in Morrisville, RTP, North Carolina plus our UK headquarters to a new building in Horsham, UK.